APPLICATION
ANDA208014
TYPE
ANDA
ORIGINAL APPROVAL
2019-12-04
LATEST ACTION
2024-12-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
FINGOLIMOD HYDROCHLORIDEDiscontinued
FINGOLIMOD HYDROCHLORIDE EQ 0.5MG BASE · CAPSULE · ORAL
Approval history
2024-12-17Labeling · Supplement 5 · standardAP
2024-12-17Labeling · Supplement 3 · standardAP
2024-12-17Labeling · Supplement 4 · standardAP
2019-12-04UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.